Cardiovascular Pharmacotherapeutics

The definitive guide for practicing physicians and pharmacists who need to know about drug therapy for heart conditions. The fully updated Second Edition explores mechanisms of action, all the cardiovascular agents now available, drugs in development, molecular biological advances, and specific drug treatments.

• Part 1 Introductory Chapters

• 1. Basic Principles
• 2. Placebo Effect
• 3. Compliance
• 4. New Drug Development
• 5. Pharmacoeconomics
• 6. Cardiovascular Pharm History

• Part 2 Drug Classes

• 7. Alpha & Beta blockers
• 8. Cholinergic & Anticholinergic Drugs
• 9. Calcium blockers
• 10. RAS ' ACE, ARBs
• 11. Diuretic
• 12. Mag, K+, Calcium
• 13. Digitalis and Inotropic Agents
• 14. Organic Nitrates and nitroprusside
• 15. Central Action, Ganglionic blockers, neuron depletors
• 16. Nonspecific antihypertensive vasodilators
• 17. Antiarrhythmics
• 18. Antiplatelets & Antithrombotics
• 19. Thrombolytics
• 20. Lipid lowering/effects of CV drugs on lipoproteins
• 21. Combination
• 22. Smoking, nicotine
• 23. Fish oils
• 24. Antioxidant vitamins and free radical scavengers
• 25. Prostacyclin
• 26. Dopamine

• Part 3 New Drugs Classes in Development

• 27. Natriuretic peptides and neutral endopeptidase
• 28.Potassium channel and sodium-hydrogen channel
• 29.Serotonin
• 30.Imidazoline
• 31. Endothelin
• 32.Adenosine
• 33.Nitric oxide
• 34.Renin
• 35.Vasopressin
• 36.Hormones
• 37.Innovative approaches for myocardial ischemia ' focus on angiogenesis
• 38.Angiogenesis
• 39.Innovative drug targets
• 40. Restenosis
• 41.Gene therapy
• 42. Apoptosis
• 43.Matrix Metalloproteinase
• 44. NSAIDS & Cox 2 inhibitors
• 45. Prostaglandins & P450 Metabolites
• 46.Innovative med. approaches to hyperlipidemia

• Part IV Special Topics

  Part V Appendices